chrX-53255834-C-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_001111125.3(IQSEC2):c.965G>A(p.Ser322Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000116 in 1,210,445 control chromosomes in the GnomAD database, including 1 homozygotes. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000012 ( 1 hom. 5 hem. )
Consequence
IQSEC2
NM_001111125.3 missense
NM_001111125.3 missense
Scores
2
8
5
Clinical Significance
Conservation
PhyloP100: 6.04
Publications
1 publications found
Genes affected
IQSEC2 (HGNC:29059): (IQ motif and Sec7 domain ArfGEF 2) This gene encodes a guanine nucleotide exchange factor for the ARF family of small GTP-binding proteins. The encoded protein is a component of the postsynaptic density at excitatory synapses, and may play a critical role in cytoskeletal and synaptic organization through the activation of selected ARF substrates including ARF1 and ARF6. Mutations in this gene have been implicated in nonsyndromic X-linked cognitive disability. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
IQSEC2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
- intellectual disability, X-linked 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.29205424).
BP6
Variant X-53255834-C-T is Benign according to our data. Variant chrX-53255834-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435522.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IQSEC2 | NM_001111125.3 | c.965G>A | p.Ser322Asn | missense_variant | Exon 3 of 15 | ENST00000642864.1 | NP_001104595.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IQSEC2 | ENST00000642864.1 | c.965G>A | p.Ser322Asn | missense_variant | Exon 3 of 15 | NM_001111125.3 | ENSP00000495726.1 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112421Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
112421
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000276 AC: 5AN: 181377 AF XY: 0.0000448 show subpopulations
GnomAD2 exomes
AF:
AC:
5
AN:
181377
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000118 AC: 13AN: 1098024Hom.: 1 Cov.: 31 AF XY: 0.0000138 AC XY: 5AN XY: 363410 show subpopulations
GnomAD4 exome
AF:
AC:
13
AN:
1098024
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
363410
show subpopulations
African (AFR)
AF:
AC:
0
AN:
26401
American (AMR)
AF:
AC:
0
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19384
East Asian (EAS)
AF:
AC:
0
AN:
30206
South Asian (SAS)
AF:
AC:
12
AN:
54138
European-Finnish (FIN)
AF:
AC:
0
AN:
40416
Middle Eastern (MID)
AF:
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
AC:
0
AN:
842046
Other (OTH)
AF:
AC:
1
AN:
46093
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112421Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34547 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
112421
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34547
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30918
American (AMR)
AF:
AC:
0
AN:
10689
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2657
East Asian (EAS)
AF:
AC:
0
AN:
3583
South Asian (SAS)
AF:
AC:
1
AN:
2704
European-Finnish (FIN)
AF:
AC:
0
AN:
6234
Middle Eastern (MID)
AF:
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
AC:
0
AN:
53193
Other (OTH)
AF:
AC:
0
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.725
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Nov 19, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Intellectual disability, X-linked 1 Benign:1
May 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
D
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;.;N;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;D;.
Sift4G
Uncertain
.;D;.;T;.
Polyphen
1.0
.;.;.;D;.
Vest4
0.070, 0.21
MutPred
Loss of phosphorylation at S322 (P = 0.0213);Loss of phosphorylation at S322 (P = 0.0213);Loss of phosphorylation at S322 (P = 0.0213);.;.;
MVP
0.82
MPC
1.9
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.